Factors Associated with the Use of Drug-Eluting Stents in Patients Presenting with Acute ST-Segment Elevation Myocardial Infarction

Background. Drug-eluting stents (DES) have proven clinical superiority to bare-metal stents (BMS) for the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Decision to implant BMS or DES is dependent on the patient's ability to take dual antiplatelet therapy. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez, Jose F., Doll, Jacob A., Mediratta, Anuj, Maffessanti, Francesco, Friant, Janet, Paul, Jonathan D., Blair, John E. A., Nathan, Sandeep, Jolly, Neeraj, Shah, Atman P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464005/
https://www.ncbi.nlm.nih.gov/pubmed/26106504
http://dx.doi.org/10.1155/2015/528753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464005/
https://www.ncbi.nlm.nih.gov/pubmed/26106504
http://dx.doi.org/10.1155/2015/528753

Ejemplares similares